Decomposition of the environmentally harmful gas nitrous oxide (N O) is usually performed thermally or catalytically. Selective catalytic reduction (SCR) is currently the most promising technology for N O mitigation, a multicomponent heterogeneous catalytic system that employs reducing agents such as ammonia, hydrogen, hydrocarbons, or a combination thereof. This study reports the first homogenous catalyst that performs the reduction of nitrous oxide employing readily available and cheap light alcohols such as methanol, ethanol or ethylene glycol derivatives. During the reaction, these alcohols are transformed in a dehydrogenative coupling reaction to carboxylate derivatives, while N O is converted to N and H O, later entering the reaction as substrate. The reaction is catalysed by the low-valent dinuclear ruthenium complex [Ru H(μ-H)(Me dad)(dbcot) ] that carries a diazabutadiene, Me dad, and two rigid dienes, dbcot, as ligands. The reduction of nitrous oxide proceeds with low catalyst loadings under relatively mild conditions (65-80 °C, 1.4 bar N O) achieving turnover numbers of up to 480 and turnover frequencies of up to 56 h .

Download full-text PDF

Source
http://dx.doi.org/10.1002/chem.202203632DOI Listing

Publication Analysis

Top Keywords

nitrous oxide
16
reduction nitrous
12
light alcohols
8
catalysed low-valent
8
reduction
4
oxide
4
oxide light
4
alcohols catalysed
4
low-valent ruthenium
4
ruthenium diazadiene
4

Similar Publications

Background: Inhalational anesthetic agents are a major source of potent greenhouse gases in the medical sector, and reducing their emissions is a readily addressable goal. Nitrous oxide (NO) has a long environmental half-life relative to carbon dioxide combined with a low clinical potency, leading to relatively large amounts of NO being stored in cryogenic tanks and H cylinders for use, increasing the chance of pollution through leaks. Building on previous findings, Stanford Health Care's (SHC's) NO emissions were analyzed at 2 campuses and targeted for waste reduction as a precursor to system-wide reductions.

View Article and Find Full Text PDF

Reactive oxygen species (ROS) play fundamental roles in various biological and chemical processes in nature and industries, including cell signaling, disease development and aging, immune defenses, environmental remediation, pharmaceutical syntheses, metal corrosion, energy production, etc. As such, their detection is of paramount importance, but their accurate identification and quantification are technically challenging due to their transient nature with short lifetimes and low steady-state concentrations. As a highly sensitive and selective analytical technique, surface-enhanced Raman spectroscopy (SERS) is promising for detecting ROS in real-time, enabling in situ monitoring of ROS-involved electrochemical and biochemical events with exceptional resolution.

View Article and Find Full Text PDF

Sociodemographic and Population Exposure to Upstream Oil and Gas Operations in Canada.

Int J Environ Res Public Health

December 2024

School of Health and Human Performance, Dalhousie University, Halifax, NS B3H 4R2, Canada.

Canada, as one of the largest oil and gas producer in the world, is responsible for large emissions of methane, a powerful greenhouse gas. At low levels, methane is not a direct threat to human health; however, human health is affected by exposure to pollutants co-emitted with methane. The objectives of this research were to estimate and map pollutants emitted by the oil and gas industry, to assess the demographic of the population exposed to oil and gas activities, and to characterize the impact of well density on cardiovascular- and respiratory-related outcomes with a focus on Alberta.

View Article and Find Full Text PDF

Contributions of Medical Greenhouse Gases to Climate Change and Their Possible Alternatives.

Int J Environ Res Public Health

November 2024

Institute of Marine and Environmental Technology, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

Considerable attention has recently been given to the contribution of the greenhouse gas (GHG) emissions of the healthcare sector to climate change. GHGs used in medical practice are regularly released into the atmosphere and contribute to elevations in global temperatures that produce detrimental effects on the environment and human health. Consequently, a comprehensive assessment of their global warming potential over 100 years (GWP) characteristics, and clinical uses, many of which have evaded scrutiny from policy makers due to their medical necessity, is needed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!